✦ LIBER ✦

Comparison of adverse events and efficacy between gefitinib and erlotinib in patients with non-small-cell lung cancer: a retrospective analysis

✍ Scribed by Tsukasa Yoshida, Kazuhiko Yamada, Koichi Azuma, Akihiko Kawahara, Hideyuki Abe, Satoshi Hattori, Fumie Yamashita, Yoshiaki Zaizen, Masayoshi Kage, Tomoaki Hoshino

Book ID: 118821726
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 225 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-012-0349-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in adverse events between 25

Differences in adverse events between 250mg daily gefitinib and 150mg daily erlotinib in Japanese patients with non-small cell lung cancer

✍ Togashi, Yosuke; Masago, Katsuhiro; Fujita, Shiro; Hatachi, Yukimasa; Fukuhara, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Response to gefitinib and erlotinib in N

Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

✍ Ivette F Emery; Chiara Battelli; Paul L Auclair; Kathleen Carrier; Daniel M Haye 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 574 KB

Cerebrospinal fluid concentration of gef

Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer

✍ Yosuke Togashi, Katsuhiro Masago, Satohiro Masuda… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 301 KB

Comparison of gefitinib and erlotinib ef

Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer

✍ Yu-Yun Shao; Wen-Yi Shau; Zhong-Zhe Lin; Ho-Min Chen; Raymond Kuo; James Chih-Hs 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 943 KB

Bilateral subdural hemorrhage as a possi

Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancer

✍ Kim, Jung Han; Kim, Hyeong Su; Choi, Jong Soo; Lee, Kyung Min; Shin, Young Chul; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 313 KB

P-955 Clinicopathological features and e

P-955 Clinicopathological features and efficacy of gefitinib in patients with non-small cell lung cancer (NSCLC) — Comparison between adenocarcinoma and non-adenocarcinoma

✍ Kawano, Y.; Kashii, T.; Katayama, H.; Hasegawa, Y.; Tokunaga, S.; Sumitani, M.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 151 KB